From Nasdaq: 2025-02-06 10:02:00

Regeneron Pharmaceuticals has initiated a $3 billion buyback program, totaling $4.5 billion in buyback capacity, representing 6% of its market capitalization. They are also starting a quarterly cash dividend program. Shares rose nearly 5% post-earnings, with beats on revenue and adjusted EPS.

PayPal announced a massive $15 billion stock repurchase program, adding to its $5 billion remaining buyback authority. Despite beating revenue and earnings estimates, shares dropped about 13% post-earnings due to concerns about branded total payment volume.

UBS Group authorized a $3 billion buyback program, representing 3% of its market capitalization. They plan to buy back $1 billion in stock in the first half of 2025 and $2 billion in the second half. The Swiss government’s new capital requirement rules could impact their buyback plans.

Jacobs Solutions announced a $1.5 billion share repurchase authorization, adding to $271 million from its 2023 program. Their total buyback capacity is nearly 11% of its $16 billion market capitalization. Revenue increased by 5% last quarter, while adjusted EPS fell over 8%.



Read more at Nasdaq:: Billions in Buybacks: 4 Stocks Rewarding Shareholders Now